Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the safety,
tolerability, pharmacokinetics (the exposure of the trial drug in the body) and
pharmacodynamics (the effect of the investigated drug on the body) of insulin degludec
(insulin 454), an explorative formulation, not similar to the proposed commerical
formulation.